Keyphrases
Acute Lymphoblastic Leukemia
100%
Hematotoxicity
85%
6-mercaptopurine (6-MP)
76%
Maintenance Therapy
60%
Indonesian children
57%
Leukemia children
43%
6-methylmercaptopurine
37%
Leukemia Patients
36%
6-Thioguanine (6-TG)
34%
Indonesia
31%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
31%
Doxorubicin
28%
Mangifera Indica
28%
Genetic Variability
28%
Doxorubicin-induced Cardiotoxicity
28%
Dari
28%
MASES
28%
Allergology
28%
Omalizumab
28%
Academy
28%
Pada
28%
Histamin
28%
Clinical Immunology
28%
World Allergy Organization
28%
Erythrocytes
28%
Development Validation
28%
Method Validation
28%
NUDT15 Polymorphism
28%
Mercaptopurine
28%
Anemia
25%
Neutropenia
25%
Genotype
23%
Thiopurine Methyltransferase
22%
Maintenance Phase
22%
NUDT15
22%
Thrombocytopenia
20%
Mangiferin
19%
Cardiac Toxicity
19%
Sylimarin
14%
Cardiac Tissue
14%
Allergy
14%
Cysteinyl Leukotrienes
14%
Leukotriene B4 (LTB4)
14%
GA2LEN
14%
Asthma
14%
Antara
14%
Network of Excellence
14%
Pediatric Patients
12%
Disease Stratification
11%
Protective Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Blood Toxicity
85%
Mercaptopurine
78%
Tioguanine
34%
Mango
28%
Cardiotoxicity
28%
Doxorubicin
28%
Midazolam
28%
Neutropenia
25%
Anemia
25%
Thiopurine Methyltransferase
22%
Thrombocytopenia
20%
Omalizumab
19%
Immunoglobulin E
19%
Chlorpheniramine Maleate
19%
Histamine
19%
Mangiferin
14%
Diseases
11%
Silymarin
10%
Antioxidant
10%
Asthma
9%
Peptidoleukotriene
9%
Fenofibrate
9%
Prevalence
9%
Serum Albumin
8%
Malonaldehyde
7%
Superoxide Dismutase
7%
Antioxidant Capacity
7%
Lactate Dehydrogenase
7%
Alpha Tocopherol
7%
Formate
7%
Bisoprolol
7%
Acetonitrile
7%
Vincristine
5%
Observational Study
5%
Dexamethasone
5%
Methotrexate
5%